Skip to main content
. 2020 Oct 31;12(11):3211. doi: 10.3390/cancers12113211

Table 3.

Blood analysis for evaluation of systemic toxicity (n = 5, mean ± SD).

Analysis Item 1 Unit Control LipCP ImmuLipCP
Hematology WBC 103 cells/μL 3.2 ± 0.35 3.1 ± 1.62 3.2 ± 0.45
RBC 106 cells/μL 7.9 ± 0.33 7.3 ± 0.28 7.4 ± 0.25
HGB g/dL 12.5 ± 0.82 11.8 ± 0.83 11.7 ± 0.43
HCT % 37.6 ± 1.38 35.0 ± 1.17 32.7 ± 2.04
PLT 103 cells/μL 992 ± 174.9 1041.3 ± 140.5 1038.7 ± 277.8
Clinical Chemistry AST U/L 428.3 ± 75.9 440.3 ± 100 375 ± 184.6
ALT U/L 53.3 ± 13.9 55.7 ± 11.0 53.7 ± 20.7
BUN mg/dL 31.0 ± 1.73 33.7 ± 2.49 31.5 ± 2.49
CREA mg/dL 0.23 ± 0.06 0.27 ± 0.05 0.25 ± 0.01

1 WBC: white blood cell; RBC: red blood cell; HGB: hemoglobin; HCT: hematocrit; PLT: platelet; AST: aspartate transaminase; ALT: alanine transaminase; BUN: blood urea nitrogen; CREA: creatinine Values are means ± standard deviation (SD) of four independent measurements.